Granite Investment Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-395,810
Closed -$17.3M 262
2023
Q3
$17.3M Buy
395,810
+860
+0.2% +$42K 0.73% 49
2023
Q2
$19.5M Sell
394,950
-3,628
-0.9% -$167K 0.78% 45
2023
Q1
$16.5M Sell
398,578
-2,666
-0.7% -$111K 0.69% 59
2022
Q4
$17.8M Sell
401,244
-5,947
-1% -$248K 0.74% 52
2022
Q3
$15.9M Buy
407,191
+185,481
+84% +$8.49M 0.69% 56
2022
Q2
$9.06M Buy
+221,710
New +$10.5M 0.38% 96

Other funds holding ATRC

Granite Investment Partners's ATRC Position: Q4 2023 in Review

Granite Investment Partners sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 395,810 shares — an estimated $17.3M sold.

Granite Investment Partners first reported a position in ATRC in Q2 2022 and held it in 6 quarters. The position peaked at $19.5M in Q2 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Granite Investment Partners reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Granite Investment Partners sold 395,810 AtriCure shares in Q4 2023, an estimated $17.3M.
  • Granite Investment Partners first reported a position in AtriCure in Q2 2022 and held it in 6 quarters.
  • Granite Investment Partners's AtriCure position peaked at $19.5M in Q2 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Granite Investment Partners's 13F filing for Q4 2023, filed 14 Feb 2024.